196 related articles for article (PubMed ID: 19032406)
1. Transrectal ultrasound and prostate-specific antigen in prostate cancer.
Lavoipierre AM
J Med Imaging Radiat Oncol; 2008 Oct; 52(5):530. PubMed ID: 19032406
[No Abstract] [Full Text] [Related]
2. Transrectal ultrasound in detecting prostate cancer compared with serum total prostate-specific antigen levels.
Tamsel S; Killi R; Hekimgil M; Altay B; Soydan S; Demirpolat G
J Med Imaging Radiat Oncol; 2008 Feb; 52(1):24-8. PubMed ID: 18373822
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen and transrectal ultrasound of the prostate in detection of prostate cancer.
Cooner WH
Clin Invest Med; 1993 Dec; 16(6):471-4. PubMed ID: 7516834
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer prediction using the random forest algorithm that takes into account transrectal ultrasound findings, age, and serum levels of prostate-specific antigen.
Xiao LH; Chen PR; Gou ZP; Li YZ; Li M; Xiang LC; Feng P
Asian J Androl; 2017; 19(5):586-590. PubMed ID: 27586028
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
[TBL] [Abstract][Full Text] [Related]
6. Re: Al-Azab R, Toi A, Lockwood G, et al. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL (Urology 69:103-107, 2007).
Stephan C; Jung K; Lein M; Deger S
Urology; 2008 Oct; 72(4):951. PubMed ID: 18926253
[No Abstract] [Full Text] [Related]
7. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
[TBL] [Abstract][Full Text] [Related]
8. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL.
Al-Azab R; Toi A; Lockwood G; Kulkarni GS; Fleshner N
Urology; 2007 Jan; 69(1):103-7. PubMed ID: 17270628
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing prostate cancer: getting to the core question.
Hernandez DJ
J Urol; 2013 Jul; 190(1):11-2. PubMed ID: 23608039
[No Abstract] [Full Text] [Related]
10. Impact of training level of urology residents on the detection of prostate cancer on TRUS biopsy.
Karam JA; Shulman MJ; Benaim EA
Prostate Cancer Prostatic Dis; 2004; 7(1):38-40. PubMed ID: 14999236
[TBL] [Abstract][Full Text] [Related]
11. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced gray-scale transrectal ultrasound-guided prostate biopsy in men with elevated serum prostate-specific antigen levels.
Yang JC; Tang J; Li J; Luo Y; Li Y; Shi H
Acad Radiol; 2008 Oct; 15(10):1291-7. PubMed ID: 18790401
[TBL] [Abstract][Full Text] [Related]
13. Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy.
Park BK; Lee HM; Kim CK; Choi HY; Park JW
Invest Radiol; 2008 Nov; 43(11):789-93. PubMed ID: 18923258
[TBL] [Abstract][Full Text] [Related]
14. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
[TBL] [Abstract][Full Text] [Related]
15. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
[TBL] [Abstract][Full Text] [Related]
16. Transrectal prostate biopsy.
Ismail MT; Gomella LG
Urol Clin North Am; 2013 Nov; 40(4):457-72. PubMed ID: 24182969
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of cancer of the prostate by determining the blood levels of specific prostatic antigen, rectal examination, and transrectal echography].
Isa Kroon WA; Robles JE; de Castro F; Rosell D; Abad JI; Zudaire JJ; Berián JM
Actas Urol Esp; 1993 Jun; 17(6):341-5; discussion 345-6. PubMed ID: 7690176
[TBL] [Abstract][Full Text] [Related]
18. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
Shao Q; Song J; Zhou ZJ; Du LD
Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
[TBL] [Abstract][Full Text] [Related]
19. A role of multifactorial evaluation of prostatic 3T MRI in patients with elevated prostatic-specific antigen levels: prospective comparison with ultrasound-guided transrectal biopsy.
Ferda J; Kastner J; Hora M; Hes O; Fínek J; Topolčan O; Kreuzberg B
Anticancer Res; 2013 Jun; 33(6):2791-5. PubMed ID: 23749943
[TBL] [Abstract][Full Text] [Related]
20. New indicator for prostate gland biopsy when malignancy is in question.
Haroun AA
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):61-6. PubMed ID: 21196614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
